Ofloxacin therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use*; D001842:Bone and Bones / Q000032:analysis; D015242:Ofloxacin; D010019:Osteomyelitis / Q000188:drug therapy*; D010078:Oxazines / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011817:Rabbits
D000900:Anti-Bacterial Agents; D010078:Oxazines; D015242:Ofloxacin